Geistlich Pharma has entered an exclusive national distribution collaboration agreement with StimLabs in the US, focusing on the commercialisation of the former’s Advanced Wound Matrix, Derma-Gide.
The buildup of these cells in tissues like the skin slows down the ... The treated skin showed fewer signs of cellular aging, and when small wounds were created, they healed much faster compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results